Knight Therapeutics(DE:04K)
€7.300.05 (-0.68%)
DE:04K
Knight Therapeutics Revenue
€7.30
At close:0.05 (-0.68%)
Knight Therapeutics (04K) Revenue
0 Followers
Knight Therapeutics Revenue
Knight Therapeutics had a revenue of 137.69M in the quarter ending Sep 30, 2026, with -4.52%. This bring the company's revenue in the last twelve months to 563.45M, Increased 2.95%. In the fiscal year ending Dec 31, 2025, Knight Therapeutics had annual revenue of 450.09M with 21.22% growth.
- Revenue (ttm)
- 563.45M
- Revenue Growth
- 30.84%
- P/S Ratio
- 1.65
- Revenue/Employee
- EUR 542,275
- Employees
- 830
- Market Cap
- EUR 744.25M
Revenue Chart
Knight Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 450.09M | 78.78M | 21.22% |
| Dec 31, 2024 | 371.30M | 43.10M | 13.13% |
| Dec 31, 2023 | 328.20M | 34.64M | 11.80% |
| Dec 31, 2022 | 293.56M | 50.09M | 20.57% |
| Dec 31, 2021 | 243.48M | 43.96M | 22.03% |
| Dec 31, 2020 | 199.52M | 152.06M | 320.39% |
| Dec 31, 2019 | 47.46M | 34.96M | 279.69% |
| Dec 31, 2018 | 12.50M | 3.87M | 44.78% |
| Dec 31, 2017 | 8.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.